10-101007398-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001318100.2(LZTS2):c.*230C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.257 in 1,422,692 control chromosomes in the GnomAD database, including 50,346 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6580 hom., cov: 33)
Exomes 𝑓: 0.25 ( 43766 hom. )
Consequence
LZTS2
NM_001318100.2 3_prime_UTR
NM_001318100.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.245
Genes affected
LZTS2 (HGNC:29381): (leucine zipper tumor suppressor 2) The protein encoded by this gene belongs to the leucine zipper tumor suppressor family of proteins, which function in transcription regulation and cell cycle control. This family member can repress beta-catenin-mediated transcriptional activation and is a negative regulator of the Wnt signaling pathway. It negatively regulates microtubule severing at centrosomes, and is necessary for central spindle formation and cytokinesis completion. It is implicated in cancer, where it may inhibit cell proliferation and decrease susceptibility to tumor development. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LZTS2 | ENST00000454422.2 | c.*230C>G | 3_prime_UTR_variant | Exon 5 of 5 | 2 | NM_001318100.2 | ENSP00000416972.2 | |||
LZTS2 | ENST00000370220.1 | c.*230C>G | 3_prime_UTR_variant | Exon 4 of 4 | 1 | ENSP00000359240.1 | ||||
LZTS2 | ENST00000370223.7 | c.*230C>G | 3_prime_UTR_variant | Exon 5 of 5 | 1 | ENSP00000359243.3 |
Frequencies
GnomAD3 genomes AF: 0.282 AC: 42880AN: 152066Hom.: 6568 Cov.: 33
GnomAD3 genomes
AF:
AC:
42880
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.303 AC: 17884AN: 58980Hom.: 3076 AF XY: 0.300 AC XY: 9227AN XY: 30726
GnomAD3 exomes
AF:
AC:
17884
AN:
58980
Hom.:
AF XY:
AC XY:
9227
AN XY:
30726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.254 AC: 323329AN: 1270508Hom.: 43766 Cov.: 31 AF XY: 0.255 AC XY: 157049AN XY: 616668
GnomAD4 exome
AF:
AC:
323329
AN:
1270508
Hom.:
Cov.:
31
AF XY:
AC XY:
157049
AN XY:
616668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.282 AC: 42921AN: 152184Hom.: 6580 Cov.: 33 AF XY: 0.283 AC XY: 21078AN XY: 74394
GnomAD4 genome
AF:
AC:
42921
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
21078
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1400
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at